• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Biogen Inc. (BIIB)

    -NasdaqGS
    252.20 Up 2.21(0.88%) 4:00PM EST
    |After Hours : 250.82 Down 1.38 (0.55%) 7:58PM EST
    Prev Close:249.99
    Open:253.35
    Bid:249.90 x 100
    Ask:252.18 x 100
    1y Target Est:354.94
    Beta:0.512311
    Earnings Date:Apr 22 - Apr 26 (Est.)
    Day's Range:249.28 - 257.37
    52wk Range:243.85 - 480.18
    Volume:1,763,503
    Avg Vol (3m):1,878,520
    Market Cap:55.15B
    P/E (ttm):16.44
    EPS (ttm):15.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.88%55.15B
    PFEUp 1.34%182.06B
    ABTUp 0.57%55.51B

    Key Statistics

    Forward P/E (1 yr):12.53
    P/S (ttm):5.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :18.63
    Quarterly EPS Est (Mar-16) :4.46
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback